OLMA Net Income Growth
-43.76%TTM
Period ending:
OLMA TTM Net Income YoY %%
53.87%-402.27%
2021-09-302026-06-30
Source: Financial Modeling Prep (FMP). Trailing twelve months (TTM). TTM flows use four complete reported quarters. Growth compares with the corresponding period one year earlier.
OLMA net income growth history
Year-over-year net income growth rate. The available trailing twelve months (ttm) series contains 20 observations from Sep 30, 2021 to Jun 30, 2026.
| Period ending | Net Income Growth |
|---|---|
| -43.7626% | |
| -43.6471% | |
| -25.47% | |
| -22.2353% | |
| -29.8004% | |
| -29.7507% | |
| -33.9548% | |
| -27.7081% | |
| -12.6912% | |
| 9.7271% | |
| 7.7605% | |
| 4.1737% | |
| -2.143% | |
| -39.6715% | |
| -47.388% | |
| -68.229% | |
| -91.5507% | |
| -120.2785% | |
| -221.396% | |
| -358.1302% |
Compare net income growth
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Brightspring Health Services Inc (BTSG) net income growth
- Ensign Group Inc (ENSG) net income growth
- Krystal Biotech Inc (KRYS) net income growth
- Protagonist Therapeutics Inc (PTGX) net income growth
- Tg Therapeutics Inc (TGTX) net income growth
- Healthequity Inc (HQY) net income growth
- Pacs Group Inc (PACS) net income growth
- Alkermes (ALKS) net income growth
Compare all covered stocks by net income growth →
All OLMA financial metrics · OLMA stock overview · How to interpret financial metrics
